AX
AXIM Biotechnologies, Inc.
AXIM · OTC
$0.00 +0.00% (+$0.00)
1M -2.86%
Market Cap $1.16M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
194.1% upside
Current Price
$0.0034
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AXIM is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
88 /100
Cheap P/S 2.95x
P/FCF 1.64x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
30 /100
Weak Gross margin 8.71%
Net margin 208.79%
Op. margin 268.08%
Quality
59 /100
Average ROIC 36.82%
ROA 24.88%
Asset turnover 0.12x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -2.83x
Debt/Equity N/A
Stability
29 /100
Unstable Beta -0.11x
Rev. volatility 224.10%
EPS volatility 39.69%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AXIM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Catalina Valencia
Employees
7
Headquarters
San Diego